Core Viewpoint - The article discusses the author's investment philosophy, which incorporates various strategies including fundamental, technical, and momentum investing, aimed at enhancing the investment process [1]. Group 1 - The author emphasizes a diversified investment approach, leveraging the strengths of fundamental, technical, and momentum investing [1]. - The purpose of writing on Seeking Alpha is to track investment ideas and connect with like-minded investors [1].

Company opens nine new outpatient imaging centers, expanding access to high-quality, cost-effective care RALEIGH, N.C., Jan. 8, 2026 /PRNewswire/ -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, set a company record by opening nine de novo centers in 2025. The two newest centers, located in Anderson, South Carolina and Cotswold, North Carolina, opened in December. With these new locations Lumexa Imaging now operates more than 185 centers across 13 state ...

RALEIGH, N.C., Jan. 5, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the 44th Annual J.P. Morgan Healthcare Conference, being held in San Francisco, California, including a presentation at 7:30am PST on Monday, January 12, 2026. A webcast link and related presentation materials will be available online at https://ir. ...

回顾：上周10只新股上市，其中9只募资规模过亿美元。 JM Group(JMG)以每股4美元，发行了375万股，募集了1500万美元。 Wealthfront (WLTH)以每股14美元，发行了3462万股，募集资金4.85亿美元。 Lumexa Imaging Holdings(LMRI)以每股18.5美元，发行了2500万股，募集了4.63亿美元。 Cardinal Infrastructure (CDNL)以每股21美元，发行了1150万股，募集了2.42亿美元。 SPAC Bluerock Acquisition(BLRKU)、carbon Capital Partner(KBONU)、Meshflow Acquisition (MESHU)、Daedalus Special Acquisition (DSACU)、 ITHAX Acquisition III (ITHAU)、Twelve Seas III (TWLVU)分别募集了1.5亿美元、3亿美元、3亿美元、2.25亿美元、2亿美元、1.5亿美元。 此外，12家公司递交招股书，含1家中企——栢威医药(AED)，详情请见：快讯丨3只新股在美上市 ...

Core Insights - The U.S. IPO market saw four companies go public and six SPACs listed last week, with eight companies filing for IPOs and four for SPACs [1][4]. Group 1: IPO Highlights - Wealthfront (WLTH) priced at the upper end of its range, raising $485 million with a market cap of $2.6 billion, targeting young "digital-first" customers and boasting over 1.3 million paying clients and $88.2 billion in assets by July 2025 [1]. - Lumexa (LMRI) raised $463 million with a market cap of $1.8 billion, operating 184 outpatient imaging centers across 13 states, and has a high leverage ratio of 3.7 times [2]. - Cardinal Infrastructure (CDNL) raised $242 million with a market cap of $769 million, focusing on utility installation services in the Southeastern U.S. with a backlog valued at $646 million [3]. - JM Group (JMG) raised $15 million with a market cap of $79 million, specializing in merchandise sourcing for various retail categories [3]. Group 2: SPAC Highlights - Six SPACs completed pricing last week, including Meshflow Acquisition (MESHU) and Karbon Capital Partners (KBONU), each raising $300 million targeting blockchain infrastructure and energy sectors respectively [4]. - Other SPACs included Daedalus Special Acquisition (DSACU) raising $225 million for consumer-facing AI and technology, and Twelve Seas III (TWLVU) raising $150 million for investments in oil and gas companies outside the U.S. [4]. Group 3: Upcoming IPOs - Medline (MDLN) plans to raise $5 billion at a market cap of $37.3 billion, focusing on medical supplies distribution, facing recent tariff pressures [8]. - Andersen (ANDG) aims to raise $165 million at a market cap of $1.74 billion, providing tax and advisory services with a 15% CAGR since 2003 [8].

Core Insights - Lumexa Imaging Holdings (LMRI) experienced modest gains on its first day of trading, indicating a positive market reception for the company [1] - The company is positioned for growth through mergers and acquisitions in the diagnostic imaging services sector, highlighting the importance of the offering proceeds for its operational management [1] Company Overview - Lumexa Imaging Holdings is focused on the diagnostic imaging services industry, which is currently undergoing M&A-driven growth [1] - The company aims to leverage the capital raised from its initial public offering to enhance its operational capabilities and manage its growth strategy effectively [1] Market Context - The IPO market is seeing increased activity, with companies like Lumexa Imaging Holdings seeking to capitalize on favorable conditions for raising capital through public offerings [1] - The diagnostic imaging services sector is highlighted as a critical area for investment, driven by ongoing consolidation and the need for enhanced service offerings [1]

Core Insights - Lumexa Imaging Holdings, Bluerock Acquisition, and Carbon Capital Partners collectively raised $913 million upon their NASDAQ debut on December 11 [1] - Lumexa Imaging Holdings opened at $18.65 per share, slightly above its offering price, and closed at $18.52, with a total market capitalization of $1.751 billion [1][4] - Lumexa Imaging reported revenues of $755 million and a net loss of $18.41 million for the nine months ending September 30, 2025 [4] New Listings - Lumexa Imaging Holdings (LMRI) raised $463 million by issuing 25 million shares at $18.50 each, with funds allocated for repaying existing loans and general corporate purposes [4] - Bluerock Acquisition (BLRKU) and Carbon Capital Partners (KBONU) also listed on the same day, raising $150 million and $300 million respectively [5] IPO Filings - Brand Meditech Limited, a Chinese company, filed for an IPO with plans to list on NASDAQ under the ticker AED, aiming to raise between $6.3 million and $8.1 million by offering 900,000 shares at $7 to $9 each [6][10] - Brand Meditech specializes in medical devices and software, including infusion pumps and portable X-ray machines, targeting various medical fields [10] Financial Data - For the fiscal years ending March 31, 2024, and 2025, Brand Meditech reported revenues of $2.619 million and $2.549 million, with net profits of $1.47 million and $1.21 million respectively [11]

Core Viewpoint - Lumexa Imaging, a provider of outpatient imaging diagnostic services, has successfully launched on the US stock market with an opening price of $18.8, slightly above its IPO price of $18.5 [1] Company Overview - Lumexa Imaging is headquartered in North Carolina and operates 184 diagnostic centers across 13 states in the US [1] - The company was co-founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, starting with only 20 centers [1] - Lumexa Imaging has expanded through 20 acquisitions and the establishment of 41 new locations [1] Services Offered - The company provides a range of advanced and routine imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography [1] Network and Partnerships - Lumexa Imaging has developed a diversified referral network, collaborating with over 29,000 medical institutions and approximately 100,000 physicians [1] Financial Performance - The company reported projected sales of $1 billion for the 12 months ending September 30, 2025 [1]

Core Viewpoint - Lumexa Imaging, a provider of outpatient imaging diagnostic services, has successfully launched on the US stock market with an opening price of $18.8, slightly above its IPO price of $18.5 [1] Company Overview - Lumexa Imaging is headquartered in North Carolina and operates 184 diagnostic centers across 13 states in the US [1] - The company was founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, starting with only 20 centers [1] - Lumexa Imaging has expanded through 20 acquisitions and the establishment of 41 new locations [1] Services Offered - The company provides a range of advanced and routine imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography [1] Network and Partnerships - Lumexa Imaging has developed a diversified referral network, collaborating with over 29,000 healthcare institutions and approximately 100,000 physicians [1] Financial Performance - The company reported a sales figure of $1 billion for the 12 months ending September 30, 2025 [1]

Core Insights - Lumexa Imaging (LMRI.US) debuted on the US stock market with an opening increase of over 1.6%, trading at $18.8, after an IPO price of $18.5 [1] Company Overview - Lumexa Imaging is a national outpatient diagnostic imaging service provider based in North Carolina, operating 184 diagnostic centers across 13 states in the US [1] - The company offers a range of advanced and routine imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography [1] - Founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, Lumexa Imaging initially started with 20 centers and has since expanded through 20 acquisitions and the opening of 41 new locations [1] Business Network and Financials - Lumexa Imaging has established a diversified referral network, collaborating with over 29,000 medical institutions and approximately 100,000 physicians [1] - The company reported projected sales of $1 billion for the 12 months ending September 30, 2025 [1]